Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril

NCT02654678 is registered in ClinicalTrials.gov with Ethicare GmbH as lead sponsor.

NCT NCT02654678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
Lead sponsor
Ethicare GmbH
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2016
Completion date
April 30, 2018
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, dilated cardiomyopathy, heart failure